Filing Details
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ADGM
Adagio Medical Holdings, Inc. (ADGM) Files Quarterly Report for Q0
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Adagio Medical Holdings, Inc. (NASDAQ: ADGM) filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026.
- The company's stock trades at $0.72 per share with a market capitalization of $15.2 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Adagio Medical Holdings, Inc.'s stock currently trades at $0.72 with a market capitalization of $15.2M.
The 10-Q provides Adagio Medical Holdings, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Adagio Medical Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ADGM Stock Page
Frequently Asked Questions
Where can I read ADGM's SEC filings?
Browse all filings on our ADGM SEC filings page.
What types of SEC filings does Adagio Medical Holdings, Inc. file?
Public companies like Adagio Medical Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.